Subscriptions

Advertising

Resources

About Us

Contact Us

Create An Account Forgot Your Password?
Trouble logging in or creating an account? click here
Home This Month E-Weekly Newsletter Building a Facility Article Archive Second Opinions
Search:
Benchmarking
General Surgery
Accrediting/Quality
Anesthesia
Code/Bill/Reimburse
Building/Renovating
/_media/adv/web/images/2012/20120123_PDI_LB-154x100.gif
/_media/adv/web/images/2012/20120126_ASP_LB-154x100.gif
/_media/adv/web/images/2012/20120126_APIC_LB-154x100.jpg
/_media/adv/web/images/2011/20111202_Arthrex_LB-154x100.jpg
Outpatient Surgery E-Weekly

Contact Congress Over Drug Shortage Issues

A Kentucky congressman is urging surgical facilities to contact their members of Congress and request that they sign his letter demanding changes to...

N.J. Posts ASC Inspection Reports Online

State and federal inspection reports of New Jersey's ASCs are now available online, giving patients an opportunity to make more informed choices abo...

Are Opioids Necessary?

While it's not always practical, or even possible, to eliminate opioids from your post-op pain management regiment, reducing their use in favor of n...

Home > News > November, 2008

CMS Seeks to Limit Coverage for Bariatric Surgery to Treat Diabetes

Proposed rule would only cover the procedure for morbidly obese beneficiaries.

Published: November 18, 2008
Categories: News, Bariatric Surgery

The Centers for Medicare & Medicaid Services has proposed limiting its coverage of bariatric surgery for the treatment of type 2 diabetes to beneficiaries who are considered morbidly obese. Patients who do not meet the criteria for morbid obesity — a body mass index of 35 or greater — but do have type 2 diabetes would not be eligible for Medicare coverage for bariatric surgery.

"While recent medical reports claimed that bariatric surgery may be helpful for" patients with a BMI less than 35 who have type 2 diabetes, CMS says it "did not find convincing medical evidence that bariatric surgery improved health outcomes for non-morbidly obese individuals."

The agency is accepting public comments on the draft rule on its Web site for 30 days and will issue a final decision within 90 days. Private insurers are likely to consider CMS’ ruling when deciding whether to cover bariatric surgery for non-obese patients. According to Reuters, the procedure can cost between $15,000 and $35,000 "for more complicated gastric bypass."

For more on weight-loss surgery procedures and their coverage limits, see "The State of Bariatric Surgery" in Outpatient Surgery Magazine’s 2008 Manager’s Guide to Overweight Patients.

Irene Tsikitas

© Copyright Herrin Publishing Partners LP 2011. REPRODUCTION OF THIS COPYRIGHTED CONTENT IS STRICTLY PROHIBITED. We encourage LINKING to this content; view our linking policy here.


Also in the News...

6 Tips for a Stress-Free Accreditation Survey

Are You Ready for an MH Emergency?

Just How Useful (Really) Is Gowning and Gloving?

Despite Huge Return on Their Investment, 3 Retinal Surgeons Squeezed Out of ASC Sue

14 Hospitals Pay $12M to Settle Medicare Fraud Charges Surrounding Spinal Surgery Billing

Could Your Facility Use a Spark?

Did Hospital Settle Malpractice Case to Spite Its Chief of Surgery?

© Copyright Herrin Publishing Partners LP 2011. REPRODUCTION OF THIS COPYRIGHTED CONTENT IS STRICTLY PROHIBITED. We encourage LINKING to this content; view our linking policy here.

Already have an account? Please sign in:
Email Address:
Password:
PRODUCT & SERVICE RESOURCES
Did You See This?
A showcase of products and services geared to make your facility better.

Architects' Showcase
Is a beautiful, efficient new facility in your future?
Other Articles That May Interest You
Failing Metal-On-Metal Hip Implants Leave Injuries, Uncertainty
Newspaper examines trend of patients suffering unprecedented complications.
CMS Enacting Prepayment Review for Procedures, Equipment
Demonstration program to begin Jan. 1 in selected states.
Personalized Propofol Sedation Device Still Fighting for FDA Approval
A dispute panel will hear an appeal from Sedasys' makers next month.